{"id":"https://openalex.org/W2035355653","doi":"https://doi.org/10.1034/j.1600-0609.2002.01599.x","title":"Large\u2010cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine\u2013rituximab\u2010containing regimens: natural history\u2010 or therapy\u2010related complication?","display_name":"Large\u2010cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine\u2013rituximab\u2010containing regimens: natural history\u2010 or therapy\u2010related complication?","publication_year":2002,"publication_date":"2002-02-01","ids":{"openalex":"https://openalex.org/W2035355653","doi":"https://doi.org/10.1034/j.1600-0609.2002.01599.x","mag":"2035355653","pmid":"https://pubmed.ncbi.nlm.nih.gov/12038452"},"language":"en","primary_location":{"id":"doi:10.1034/j.1600-0609.2002.01599.x","doi":"https://doi.org/10.1034/j.1600-0609.2002.01599.x","is_oa":false,"landing_page_url":"https://doi.org/10.1034/j.1600-0609.2002.01599.x","pdf_url":null,"source":{"id":"https://openalex.org/S159715054","display_name":"European Journal Of Haematology","issn_l":"0902-4441","issn":["0902-4441","1600-0609"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012837653","display_name":"Yossi Cohen","orcid":"https://orcid.org/0009-0008-8998-0709","observed_orcids":["https://orcid.org/0009-0008-8998-0709"]},"institutions":[{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Yossi Cohen","raw_affiliation_strings":["Department of Hematology, Hadassah University Hospital, Jerusalem, Israel","Departments of Hematology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Hadassah University Hospital, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Departments of Hematology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109318859","display_name":"Nael Da\u2019as","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nael Da'as","raw_affiliation_strings":["Departments of Hematology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Hematology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051760399","display_name":"Diana Libster","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Libster","raw_affiliation_strings":["Departments of Hematology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Hematology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904454","display_name":"Gail Amir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Gail Amir","raw_affiliation_strings":["Pathology, Hadassah University Hospital, Jerusalem,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Hadassah University Hospital, Jerusalem,","institution_ids":["https://openalex.org/I2799899409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113540166","display_name":"Alan Berrebi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800052317","display_name":"Kaplan Medical Center","ror":"https://ror.org/00t0n9020","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800052317","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Alan Berrebi","raw_affiliation_strings":["Department of Hematology, Kaplan Medical Center, Rehovot, Israel","Dept. of Hematology, Kaplan Medical Center, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Kaplan Medical Center, Rehovot, Israel","institution_ids":["https://openalex.org/I2800052317"]},{"raw_affiliation_string":"Dept. of Hematology, Kaplan Medical Center, Rehovot, Israel","institution_ids":["https://openalex.org/I2800052317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109106744","display_name":"Aaron Polliack","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Aaron Polliack","raw_affiliation_strings":["Departments of Hematology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Hematology and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109106744"],"corresponding_institution_ids":[],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.9965,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.87592637,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"68","issue":"2","first_page":"80","last_page":"83"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.8715999722480774,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.8715999722480774,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.12770000100135803,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/large-cell-transformation","display_name":"large cell transformation","score":0.9819999933242798},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9890000224113464},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":1.0},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.9240000247955322},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/purine-analogs","display_name":"purine analogues","score":0.8889999985694885},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8999999761581421},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7860000133514404},{"id":"https://openalex.org/keywords/therapy-related-malignancy","display_name":"therapy-related malignancy","score":0.6119999885559082},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.8783262968063354},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8518195152282715},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8099565505981445},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7322178483009338},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.7318191528320312},{"id":"https://openalex.org/C109246011","wikidata":"https://www.wikidata.org/wiki/Q6593447","display_name":"Purine analogue","level":4,"score":0.6313210725784302},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.5720049738883972},{"id":"https://openalex.org/C2777866208","wikidata":"https://www.wikidata.org/wiki/Q415939","display_name":"Chlorambucil","level":4,"score":0.5077963471412659},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5047353506088257},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5017931461334229},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.4958105981349945},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4929349422454834},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4215913712978363},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3938336670398712},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3492715358734131},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.23444685339927673},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07034435868263245},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2776476023","wikidata":"https://www.wikidata.org/wiki/Q188261","display_name":"Purine","level":3,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002471","descriptor_name":"Cell Transformation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D016609","descriptor_name":"Neoplasms, Second Primary","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D016867","descriptor_name":"Immunocompromised Host","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1034/j.1600-0609.2002.01599.x","doi":"https://doi.org/10.1034/j.1600-0609.2002.01599.x","is_oa":false,"landing_page_url":"https://doi.org/10.1034/j.1600-0609.2002.01599.x","pdf_url":null,"source":{"id":"https://openalex.org/S159715054","display_name":"European Journal Of Haematology","issn_l":"0902-4441","issn":["0902-4441","1600-0609"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:12038452","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12038452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W12757300","https://openalex.org/W61714529","https://openalex.org/W79383600","https://openalex.org/W96780237","https://openalex.org/W134090085","https://openalex.org/W1521540513","https://openalex.org/W1540507981","https://openalex.org/W1906996655","https://openalex.org/W1910831415","https://openalex.org/W1915689252","https://openalex.org/W1998641165","https://openalex.org/W2011346484","https://openalex.org/W2099314298","https://openalex.org/W2134937424","https://openalex.org/W2154242412","https://openalex.org/W2161926682","https://openalex.org/W2165963183","https://openalex.org/W2168926834","https://openalex.org/W2171464968","https://openalex.org/W2177091656","https://openalex.org/W2221772045","https://openalex.org/W2294516256","https://openalex.org/W2406321134","https://openalex.org/W2431109871","https://openalex.org/W2484073494","https://openalex.org/W3021957806","https://openalex.org/W6689292556"],"related_works":["https://openalex.org/W2037398775","https://openalex.org/W1975728691","https://openalex.org/W2594275036","https://openalex.org/W2026901410","https://openalex.org/W2247248364","https://openalex.org/W2979739019","https://openalex.org/W2400556262","https://openalex.org/W1968504802","https://openalex.org/W2049797800","https://openalex.org/W2528716568"],"abstract_inverted_index":{"Abstract:":[0],"Novel":[1],"therapeutic":[2],"regimens":[3,121,136,141,179],"containing":[4,122,142],"purine":[5],"analogs":[6],"and":[7,25,79,137,159],"monoclonal":[8],"antibodies":[9],"have":[10,29,194],"led":[11],"to":[12,40,54,67,81,162,181,198,206],"significant":[13],"improvement":[14],"in":[15,32,91,106,147,189],"the":[16,75,92,108,118,148,153,163],"course":[17,155],"of":[18,36,57,74,110,120,156,168,177],"indolent":[19,104],"lymphoproliferative":[20],"diseases":[21],"(LPD).":[22],"Complete":[23],"clinical":[24],"even":[26],"molecular":[27],"remissions":[28],"been":[30,64],"achieved":[31],"an":[33],"increasing":[34],"proportion":[35],"patients.":[37],"In":[38],"parallel":[39],"their":[41,55],"tumor":[42,89],"cytotoxic":[43],"effect,":[44],"these":[45,123,178,190],"agents":[46,124],"are":[47],"inevitably":[48],"associated":[49],"with":[50,101],"prolonged":[51],"immunosuppression":[52,78],"inherent":[53],"mechanism":[56],"antilymphocytic":[58],"activity.":[59],"Until":[60],"now,":[61],"attention":[62,205],"has":[63],"paid":[65],"mainly":[66],"opportunistic":[68],"infection":[69],"occuring":[70],"as":[71,86],"a":[72,186],"result":[73],"above":[76],"drug\u2010induced":[77],"less":[80],"other":[82],"possible":[83],"complications,":[84],"such":[85],"malignancy":[87],"or":[88,115,172],"progression":[90],"immunocompromised":[93],"host.":[94],"Here":[95],"we":[96,193],"briefly":[97],"report":[98],"nine":[99],"patients":[100],"previously":[102],"treated":[103],"LPD":[105],"whom":[107],"onset":[109,167],"large\u2010cell":[111],"transformation":[112,126],"occured":[113],"during":[114],"shortly":[116],"after":[117],"initiation":[119],"before":[125],"occured.":[127],"One":[128],"patient":[129],"had":[130],"received":[131,139],"rituximab":[132],"alone,":[133],"three":[134],"fludarabine\u2010containing":[135],"five":[138],"sequential":[140],"both":[143],"agents.":[144],"This":[145],"\u2018switch\u2019":[146],"histopathology":[149],"could":[150],"merely":[151],"reflect":[152],"natural":[154],"progressive":[157],"lymphoma":[158],"be":[160],"unrelated":[161],"therapy":[164],"given.":[165],"The":[166],"this":[169,200,207],"complication":[170],"during,":[171],"so":[173],"soon":[174],"after,":[175],"administration":[176],"seems":[180],"us":[182],"more":[183],"than":[184],"just":[185],"chance":[187],"relationship":[188],"cases;":[191],"however,":[192],"no":[195],"conclusive":[196],"evidence":[197],"prove":[199],"hypothesis":[201],"definitively.":[202],"We":[203],"draw":[204],"phenomenon.":[208]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}